MedPath

88% Phenol vs 10% NaOH in the treatment of Ingrown toe-nail

Phase 4
Conditions
Health Condition 1: L600- Ingrowing nailHealth Condition 2: null- Patients with Ingrown toe nails
Registration Number
CTRI/2013/11/004164
Lead Sponsor
Research institution and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with a clinical diagnosis of ingrown toenail, who are symptomatic presenting to the dermatology clinic of GTB hospital, with ages between 18 to 60 years.

2.Patients willing to participate in the study according to the protocol.

Exclusion Criteria

1.Those with significant peripheral arterial disease or history of chronic smoking

2.Known allergy to the chemical agents being used

3.Conditions associated with delayed wound healing e.g. Diabetes Mellitus.

4.Pregnant or lactating women.

5.Patients not consenting for surgical intervention or for inclusion in the study protocol

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.Timepoint: 1.Time to complete healing: This will be recorded in terms of the number of days taken to achieve healing of the operated area defined as discharge (Grade 0); no evidence of tissue destruction; no raw areas or erosions.
Secondary Outcome Measures
NameTimeMethod
2.Cure: This will be defined as healing along with absence of pain (score 0). The number of patients cured within each group will be recorded.Timepoint: Assessed at each visit as per protocol.;3.Recurrence: All the patients will be followed up for a minimum period of one year. Any reappearance of pain, discharge, inflammation or swelling of the nail fold in a patient who had previously been cured will counted as a recurrence.Timepoint: Assessed at each visit (as per protocol) upto a maximum of ONE YEAR
© Copyright 2025. All Rights Reserved by MedPath